Compare TransMedics Group Inc (TMDX) vs United Parcel Service Inc (UPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs United Parcel Service Inc — how do they compare? TransMedics Group Inc trades at $78.15 (market cap $2.74B), while United Parcel Service Inc trades at $94.65 (market cap $80.08B). The key difference: United Parcel Service Inc is far larger — about 29.2× TransMedics Group Inc's market cap, and United Parcel Service Inc pays a 6.97% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold TransMedics Group Inc for 24 Days and United Parcel Service Inc for 141 Days on average.
| TMDX | UPS | |
|---|---|---|
Market Cap | $2.74B | $80.08B |
Volume | 949,331 | 6,706,833 |
Sector | Health | Industrials |
52-Week High | $150.42 | $120.00 |
52-Week Low | $61.99 | $82.87 |
Typical Hold Time | 24 Days | 141 Days |
Enterprise Value | $3.13B | $104.10B |
Dividend Yield | — | 6.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $78.17, down 3.58% on the day, with a bearish technical signal and mixed earnings history. The company reported strong 2025 results with $605.49M revenue and $190.29M net income, but 2026 projections show margin compression. Recent news highlights insider buying and leadership changes alongside legal investigations into fiduciary duties, creating a complex sentiment backdrop.
The stock offers growth potential with a consensus price target of $99.75, but faces risks from earnings misses, margin pressure, and ongoing legal scrutiny. Analyst consensus remains bullish with 69% buy ratings, yet investors must weigh robust profitability metrics against execution and regulatory uncertainties.
UPS trades at $94.54, up 2.45% on the day, with a bearish technical signal but strong recent earnings beats. The stock shows a P/E of 17.5 and a 5.08% net income margin, with revenue declining to $88.66B in 2025. Analyst consensus is a Buy with a $118.67 price target, while recent news highlights margin pressures and new e-commerce initiatives like the UPS Secure Commerce platform.
The outlook is mixed: a high dividend yield near 7% and valuation support offer upside potential, but declining revenue, competitive threats from Amazon, and fuel cost headwinds pose risks. Earnings growth from cost-cutting and domestic margin improvement remains the key catalyst for stock performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About United Parcel Service Inc
United Parcel Service, Inc. (UPS) delivers packages and documents throughout the United States and in other countries and territories. The Company also provides global supply chain services and less-than-truckload transportation, primarily in the US UPS's business consists of integrated air and ground pick-up and delivery network
Read more on UPS →
